tiprankstipranks
Trending News
More News >
InnoCan Pharma (TSE:INNO)
:INNO
Canadian Market

InnoCan Pharma (INNO) Financial Statements

Compare
21 Followers

InnoCan Pharma Financial Overview

InnoCan Pharma's market cap is currently C$38.51M. The company's EPS TTM is C$-0.596; its P/E ratio is -8.10; InnoCan Pharma is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 29.44M$ 13.66M$ 2.56M$ 196.00K$ 8.00K
Gross Profit$ 26.19M$ 11.98M$ 2.11M$ 121.00K$ 3.00K
Operating Income$ -1.25M$ 3.80M$ -6.27M$ -7.48M$ -4.72M
EBITDA$ 961.00K$ -3.77M$ -3.85M$ -10.04M$ -9.90M
Net Income$ -1.83M$ -4.70M$ -3.89M$ -10.06M$ -15.18M
Balance Sheet
Cash & Short-Term Investments$ 5.01M$ 3.88M$ 4.95M$ 11.05M$ 2.34M
Total Assets$ 9.26M$ 6.94M$ 6.98M$ 12.57M$ 4.33M
Total Debt$ 10.00K$ 33.00K$ 34.00K$ 1.00K$ 38.00K
Net Debt$ -5.00M$ -3.85M$ -4.91M$ -11.05M$ -2.30M
Total Liabilities$ 2.24M$ 2.55M$ 751.00K$ 3.56M$ 7.94M
Stockholders' Equity$ 5.17M$ 4.10M$ 6.39M$ 9.05M$ -3.61M
Cash Flow
Free Cash Flow$ -1.59M$ -3.95M$ -6.09M$ -6.67M$ -3.69M
Operating Cash Flow$ -1.58M$ -3.90M$ -6.07M$ -6.63M$ -3.69M
Investing Cash Flow$ 54.00K$ -84.00K$ -31.00K$ -48.00K$ 0.00
Financing Cash Flow$ 2.70M$ 2.92M$ 125.00K$ 15.30M$ 4.02M
Currency in USD

InnoCan Pharma Earnings and Revenue History

InnoCan Pharma Debt to Assets

InnoCan Pharma Cash Flow

InnoCan Pharma Forecast EPS vs Actual EPS